These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16403498)

  • 1. Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy.
    Hara H; Yamada N; Kodama M; Matsumoto Y; Wake Y; Kuroda S
    Eur J Pharmacol; 2006 Feb; 531(1-3):59-65. PubMed ID: 16403498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
    Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
    Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T
    J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spinal antinociceptive effects of a novel competitive AMPA receptor antagonist, YM872, on thermal or formalin-induced pain in rats.
    Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
    Anesth Analg; 1999 Jul; 89(1):143-7. PubMed ID: 10389792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
    Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Yatsugi SI; Shimizu-Sasamata M; Koshiya K; Shishikura JI; Sakamoto S; Yamaguchi T
    J Pharmacol Exp Ther; 1998 Feb; 284(2):467-73. PubMed ID: 9454786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
    Terai K; Suzuki M; Sasamata M; Yatsugi Si; Yamaguchi T; Miyata K
    Eur J Pharmacol; 2003 Apr; 467(1-3):95-101. PubMed ID: 12706461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemically administered competitive AMPA receptor antagonist, YM872, has analgesic effects on thermal or formalin-induced pain in rats.
    Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
    Anesth Analg; 1999 Dec; 89(6):1534-7. PubMed ID: 10589643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Takahashi M; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Neuropharmacology; 2000 Jan; 39(2):211-7. PubMed ID: 10670416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
    De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
    Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.
    Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Ichiki C; Yatsugi SI; Koshiya K; Shimizu-Sasamata M; Yamaguchi T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):559-66. PubMed ID: 9808681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-additive anticonvulsant effect of memantine and NBQX in kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1994 Jul; 259(2):R3-5. PubMed ID: 7957602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse.
    Rogawski MA; Kurzman PS; Yamaguchi SI; Li H
    Neuropharmacology; 2001; 40(1):28-35. PubMed ID: 11077068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic analgesic effects of intrathecal midazolam and NMDA or AMPA receptor antagonists in rats.
    Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
    Can J Anaesth; 2001 Mar; 48(3):288-94. PubMed ID: 11305832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of a novel AMPA receptor antagonist, YM872.
    Small DL; Murray CL; Monette R; Kawasaki-Yatsugi S; Morley P
    Neuroreport; 1998 May; 9(7):1287-90. PubMed ID: 9631414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
    Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
    Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.